Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Lysine degradation (mmu00310)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
Aadat
KLA  ATP  ATP+KLA
 NM_011834 aminoadipate aminotransferase (Aadat), mRNA [NM_011834] KLA 1.05 1.06 1.04 .98 1.00 1.04 .98
ATP .98 .99 1.10 1.03 1.00 1.04 1.03
KLA/ATP 1.05 1.09 1.07 1.04 .97 1.06 1.05
Aass
KLA  ATP  ATP+KLA
 NM_013930 aminoadipate-semialdehyde synthase (Aass), nuclear gene encoding mitochondrial protein, mRNA [NM_013930] KLA 1.03 1.08 1.01 1.13 1.04 1.04 .99
ATP 1.00 .91 1.06 .99 .97 .95 1.01
KLA/ATP .98 1.00 1.01 .91 .96 .94 .91
Acat1
KLA  ATP  ATP+KLA
 NM_144784 acetyl-Coenzyme A acetyltransferase 1 (Acat1), nuclear gene encoding mitochondrial protein, mRNA [NM_144784] KLA 1.04 .99 .95 .99 .81 .83 .51
ATP .89 .88 1.21 .99 .67 .36 .47
KLA/ATP .86 .97 1.18 .90 .64 .42 .35
Acat2
KLA  ATP  ATP+KLA
 NM_009338 acetyl-Coenzyme A acetyltransferase 2 (Acat2), mRNA [NM_009338] KLA 1.14 1.13 1.22 1.29 1.10 .93 .81
ATP 1.04 1.05 1.16 1.35 1.20 1.53 1.16
KLA/ATP 1.19 1.19 1.41 1.29 1.13 .92 .71
Aldh1b1
KLA  ATP  ATP+KLA
 NM_028270 aldehyde dehydrogenase 1 family, member B1 (Aldh1b1), nuclear gene encoding mitochondrial protein, mRNA [NM_028270] KLA 7.51 7.83 9.27 11.57 11.10 10.78 4.79
ATP .93 .91 .90 .89 .73 2.27 2.30
KLA/ATP 6.45 7.40 9.33 9.54 8.82 12.15 10.67
Aldh2
KLA  ATP  ATP+KLA
 AK163452 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230105J09 product:aldehyde dehydrogenase 2, mitochondrial, full insert sequence [AK163452] KLA .62 .65 .59 .60 .63 .64 .49
ATP 1.01 .91 1.06 .93 1.18 .93 .41
KLA/ATP .70 .68 .70 .84 1.16 .96 .45
Aldh2
KLA  ATP  ATP+KLA
 NM_009656 aldehyde dehydrogenase 2, mitochondrial (Aldh2), nuclear gene encoding mitochondrial protein, mRNA [NM_009656] KLA .74 .81 .77 .65 .60 .53 .50
ATP .98 1.10 .90 1.17 1.04 .82 .60
KLA/ATP .84 .86 .77 .82 .72 .66 .51
Aldh3a2
KLA  ATP  ATP+KLA
 NM_007437 aldehyde dehydrogenase family 3, subfamily A2 (Aldh3a2), mRNA [NM_007437] KLA .86 .83 .79 .79 .80 .97 1.00
ATP .93 .98 .94 .89 .77 .87 1.02
KLA/ATP .78 .81 .67 .72 .65 .81 .97
Aldh7a1
KLA  ATP  ATP+KLA
 NM_138600 aldehyde dehydrogenase family 7, member A1 (Aldh7a1), mRNA [NM_138600] KLA .98 1.03 1.08 1.12 1.08 .94 .99
ATP 1.01 1.03 1.00 1.03 .98 .82 .91
KLA/ATP 1.15 1.12 1.01 1.02 .90 .89 .83
Aldh9a1
KLA  ATP  ATP+KLA
 NM_019993 aldehyde dehydrogenase 9, subfamily A1 (Aldh9a1), mRNA [NM_019993] KLA .64 .64 .67 .48 .42 .24 .33
ATP 1.07 1.02 .75 .94 .68 .46 .42
KLA/ATP .72 .65 .43 .55 .37 .31 .24
Ash1l
KLA  ATP  ATP+KLA
 NM_138679 ash1 (absent, small, or homeotic)-like (Drosophila) (Ash1l), mRNA [NM_138679] KLA 1.23 1.04 1.03 1.04 1.29 1.17 1.27
ATP 1.18 1.23 1.32 1.55 1.83 1.60 1.35
KLA/ATP 1.25 1.19 1.22 1.25 1.54 1.57 1.72
Bbox1
KLA  ATP  ATP+KLA
 NM_130452 butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 (gamma-butyrobetaine hydroxylase) (Bbox1), mRNA [NM_130452] KLA 1.05 .99 1.00 .89 .97 1.08 1.00
ATP 1.01 .99 1.05 1.02 .98 .98 1.01
KLA/ATP 1.00 .93 .91 .99 .99 .98 1.09
Dlst
KLA  ATP  ATP+KLA
 AK171100 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630223O05 product:dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex), full insert sequence [AK171100] KLA .90 .87 .88 .83 1.10 .86 1.09
ATP .97 .78 .47 .80 2.22 1.46 1.21
KLA/ATP 1.00 .91 .66 .76 1.24 1.06 1.04
Dlst
KLA  ATP  ATP+KLA
 NM_030225 dihydrolipoamide S-succinyltransferase (E2 component of 2-oxo-glutarate complex) (Dlst), mRNA [NM_030225] KLA 1.15 1.22 1.20 1.11 1.02 .97 1.13
ATP 1.02 1.01 1.02 .95 1.01 1.36 1.19
KLA/ATP 1.23 1.29 1.23 1.19 .99 .98 .99
Dot1l
KLA  ATP  ATP+KLA
 NM_199322 DOT1-like, histone H3 methyltransferase (S. cerevisiae) (Dot1l), mRNA [NM_199322] KLA .84 .87 .84 .87 .97 1.15 1.14
ATP 1.03 1.06 1.29 1.94 1.46 1.05 1.54
KLA/ATP .88 .83 1.07 1.47 1.21 1.32 1.64
Echs1
KLA  ATP  ATP+KLA
 NM_053119 enoyl Coenzyme A hydratase, short chain, 1, mitochondrial (Echs1), nuclear gene encoding mitochondrial protein, mRNA [NM_053119] KLA .57 .55 .52 .54 .60 .82 .90
ATP .99 .97 1.07 1.15 .77 .37 .81
KLA/ATP .55 .56 .55 .66 .53 .39 .41
Ehhadh
KLA  ATP  ATP+KLA
 NM_023737 enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase (Ehhadh), mRNA [NM_023737] KLA .74 .77 .80 .88 .71 .67 .74
ATP 1.02 1.06 1.04 .90 .70 .84 .83
KLA/ATP .79 .81 .80 .65 .59 .79 .55
Ehmt1
KLA  ATP  ATP+KLA
 NM_172545 euchromatic histone methyltransferase 1 (Ehmt1), transcript variant 2, mRNA [NM_172545] KLA .55 .44 .42 .44 .42 .52 .59
ATP .92 .82 1.42 .84 .60 .80 .84
KLA/ATP .46 .45 .59 .34 .54 .59 .56
Ehmt2
KLA  ATP  ATP+KLA
 NM_145830 euchromatic histone lysine N-methyltransferase 2 (Ehmt2), transcript variant long, mRNA [NM_145830] KLA .77 .74 .85 1.00 1.25 1.37 1.04
ATP .93 .92 1.05 .91 .71 .64 .90
KLA/ATP .75 .73 .90 .79 1.02 .87 1.09
Gcdh
KLA  ATP  ATP+KLA
 U18992 glutaryl-CoA dehydrogenase mRNA, complete cds. [U18992] KLA .93 .79 .71 .83 .76 .74 .79
ATP 1.03 1.08 1.25 1.15 .86 .56 .75
KLA/ATP .72 .82 1.12 .93 .68 .50 .48
Glt25d1
KLA  ATP  ATP+KLA
 NM_146211 glycosyltransferase 25 domain containing 1 (Glt25d1), mRNA [NM_146211] KLA .69 .73 .79 .60 .61 .53 .70
ATP 1.08 1.15 .97 1.12 1.03 .71 .81
KLA/ATP .80 .76 .60 .72 .53 .49 .61
Glt25d2
KLA  ATP  ATP+KLA
 NM_177756 glycosyltransferase 25 domain containing 2 (Glt25d2), mRNA [NM_177756] KLA 1.02 1.00 .97 1.01 1.03 .95 .97
ATP .97 1.05 1.03 .97 .97 .96 1.00
KLA/ATP .97 .99 1.03 1.00 .98 1.02 1.02
Hadh
KLA  ATP  ATP+KLA
 NM_008212 hydroxyacyl-Coenzyme A dehydrogenase (Hadh), nuclear gene encoding mitochondrial protein, mRNA [NM_008212] KLA .75 .75 .72 .64 .54 .37 .49
ATP 1.12 1.19 1.08 1.28 .96 .43 .41
KLA/ATP .76 .81 .68 .85 .56 .42 .21
Hadha
KLA  ATP  ATP+KLA
 AK050856 9 days embryo whole body cDNA, RIKEN full-length enriched library, clone:D030026J11 product:hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit, full insert KLA .96 .92 .91 .80 .97 .92 .90
ATP .72 .64 .63 .71 .91 .93 .93
KLA/ATP .79 .72 .68 .73 .87 .90 .88
Hadha
KLA  ATP  ATP+KLA
 NM_178878 hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit (Hadha), nuclear gene encoding mitochondrial protein, mRNA [NM_178878] KLA 1.10 1.17 1.36 1.16 1.23 1.10 1.00
ATP 1.16 1.22 1.03 1.40 1.09 .79 1.11
KLA/ATP 1.33 1.35 1.16 1.41 1.00 .92 1.31
Mll1
KLA  ATP  ATP+KLA
 NM_001081049 myeloid/lymphoid or mixed-lineage leukemia 1 (Mll1), mRNA [NM_001081049] KLA 1.48 1.42 1.39 1.11 1.28 1.10 1.12
ATP 1.08 1.08 1.16 1.22 1.77 1.14 1.00
KLA/ATP 1.59 1.62 1.59 1.37 1.89 1.23 1.28
Mll2
KLA  ATP  ATP+KLA
 XM_619357 gb|PREDICTED: Mus musculus myeloid [XM_619357] KLA 1.22 1.31 1.51 1.34 1.65 1.89 1.63
ATP 1.05 1.15 1.02 1.18 1.06 1.64 2.06
KLA/ATP 1.40 1.27 1.02 1.23 1.09 2.09 3.44
Mll3
KLA  ATP  ATP+KLA
 AK033339 15 days embryo male testis cDNA, RIKEN full-length enriched library, clone:8030497B12 product:unclassifiable, full insert sequence. [AK033339] KLA 1.10 1.14 1.04 1.11 1.02 .96 .99
ATP 1.02 1.07 .97 .91 .99 1.00 .99
KLA/ATP 1.21 1.09 .99 .88 .94 1.00 1.03
Mll3
KLA  ATP  ATP+KLA
 NM_001081383 myeloid/lymphoid or mixed-lineage leukemia 3 (Mll3), mRNA [NM_001081383] KLA 1.11 1.19 1.53 1.30 .95 1.14 1.00
ATP 1.10 1.08 1.26 1.20 .73 .98 .97
KLA/ATP 1.17 1.27 1.96 1.59 1.05 1.33 1.37
Mll5
KLA  ATP  ATP+KLA
 AK021284 12 days embryo eyeball cDNA, RIKEN full-length enriched library, clone:D230038D11 product:myeloid/lymphoid or mixed-lineage leukemia 5, full insert sequence. [AK021284] KLA .78 .76 .76 1.04 1.30 1.09 .83
ATP .94 .80 .94 .99 .66 1.03 .75
KLA/ATP .72 .65 1.07 1.03 1.08 1.10 .95
Mll5
KLA  ATP  ATP+KLA
 AK148169 B16 F10Y cells cDNA, RIKEN full-length enriched library, clone:G370040I11 product:myeloid [AK148169] KLA .82 .77 .90 1.10 1.33 1.08 .96
ATP 1.00 .82 .66 .79 .59 .82 .82
KLA/ATP .79 .72 .72 .86 .87 .85 .99
Mll5
KLA  ATP  ATP+KLA
 AK154113 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630002I20 product:hypothetical protein, full insert sequence [AK154113] KLA .92 .86 .90 .83 .84 .84 .89
ATP .92 .90 .93 .80 .76 .83 .87
KLA/ATP .84 .83 .80 .76 .77 .79 .80
Mm.13075
2
KLA  ATP  ATP+KLA
 76096373 Unknown KLA 1.29 1.10 1.11 1.17 1.19 1.30 1.11
ATP 1.13 .92 1.53 1.42 1.93 2.06 1.21
KLA/ATP 1.22 1.23 1.76 1.36 2.11 1.90 1.77
Mm.16896
5
KLA  ATP  ATP+KLA
 118918399 Unknown KLA .63 .65 .58 .64 .93 1.23 1.08
ATP 1.02 .91 .88 .54 .52 .99 1.00
KLA/ATP .70 .69 .60 .46 .59 .98 1.13
Mm.2389
KLA  ATP  ATP+KLA
 124486681 Unknown KLA 1.53 1.23 1.29 1.19 1.25 1.01 .97
ATP 1.13 .98 1.41 .90 1.87 1.09 .91
KLA/ATP 1.63 1.58 2.26 .94 1.95 1.04 1.01
Mm.24176
KLA  ATP  ATP+KLA
 157951632 Unknown KLA .58 .44 .40 .46 .43 .58 .64
ATP .87 .79 1.46 .84 .58 .81 .89
KLA/ATP .43 .45 .64 .35 .55 .69 .63
Mm.29323
3
KLA  ATP  ATP+KLA
 118130035 Unknown KLA .98 1.04 .98 1.05 1.07 .97 .95
ATP 1.02 1.04 1.01 1.02 1.00 1.00 1.00
KLA/ATP 1.03 1.00 .98 .96 1.10 1.03 .98
Mm.31830
2
KLA  ATP  ATP+KLA
 124487482 Unknown KLA 1.02 1.02 1.02 1.06 1.03 .98 1.05
ATP 1.00 .99 1.04 1.17 1.04 .98 .96
KLA/ATP 1.04 1.02 1.22 1.05 .99 .99 .99
Mm.79983
KLA  ATP  ATP+KLA
 141802971 Unknown KLA 1.84 2.28 2.15 1.72 1.25 .70 .72
ATP 1.03 1.12 1.21 1.34 1.00 .96 .56
KLA/ATP 1.94 2.19 1.87 2.10 1.40 .89 .66
Nsd1
KLA  ATP  ATP+KLA
 NM_008739 nuclear receptor-binding SET-domain protein 1 (Nsd1), mRNA [NM_008739] KLA .75 .79 .66 .78 1.02 1.26 1.21
ATP 1.01 .93 .93 .66 .60 .93 .96
KLA/ATP .80 .74 .67 .67 .77 .92 1.07
Ogdh
KLA  ATP  ATP+KLA
 NM_010956 oxoglutarate dehydrogenase (lipoamide) (Ogdh), nuclear gene encoding mitochondrial protein, mRNA [NM_010956] KLA 1.00 1.05 1.10 .95 1.06 1.08 1.30
ATP 1.10 1.28 .95 1.23 .93 1.15 1.82
KLA/ATP 1.27 1.11 .81 1.21 .76 1.13 1.83
Ogdhl
KLA  ATP  ATP+KLA
 NM_001081130 oxoglutarate dehydrogenase-like (Ogdhl), mRNA [NM_001081130] KLA 1.03 1.07 1.03 1.02 1.00 .97 .91
ATP .94 .99 .98 .99 .93 .99 1.01
KLA/ATP .97 1.02 1.03 .93 .95 .90 1.04
Pipox
KLA  ATP  ATP+KLA
 NM_008952 pipecolic acid oxidase (Pipox), mRNA [NM_008952] KLA .97 .94 1.00 1.00 .98 1.06 1.01
ATP 1.04 1.01 1.03 1.03 1.06 .93 1.01
KLA/ATP 1.03 1.12 1.07 1.06 .98 1.07 .97
Plod1
KLA  ATP  ATP+KLA
 NM_011122 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 (Plod1), mRNA [NM_011122] KLA 1.09 1.14 1.26 1.21 1.55 1.79 1.28
ATP 1.02 1.14 .86 1.15 .87 .69 .96
KLA/ATP 1.28 1.23 .89 1.23 .72 .88 1.13
Plod2
KLA  ATP  ATP+KLA
 NM_011961 procollagen lysine, 2-oxoglutarate 5-dioxygenase 2 (Plod2), mRNA [NM_011961] KLA 1.71 1.73 1.79 1.65 1.16 .71 .81
ATP 1.02 1.07 1.17 1.32 .99 .94 .64
KLA/ATP 1.66 1.80 1.55 1.81 1.18 .78 .71
Plod3
KLA  ATP  ATP+KLA
 NM_011962 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 (Plod3), mRNA [NM_011962] KLA 2.26 2.29 2.72 2.51 2.74 2.67 1.80
ATP 1.00 1.07 .98 1.26 1.08 1.20 1.58
KLA/ATP 2.42 2.55 2.57 2.97 2.24 2.17 1.96
Setd1a
KLA  ATP  ATP+KLA
 NM_178029 SET domain containing 1A (Setd1a), mRNA [NM_178029] KLA .78 .66 .65 .67 .71 .82 .92
ATP .95 .92 .97 .85 1.50 2.22 1.07
KLA/ATP .72 .71 .72 .60 1.26 1.77 1.16
Setd1b
KLA  ATP  ATP+KLA
 BC038367 SET domain containing 1B, mRNA (cDNA clone MGC:39035 IMAGE:5364810), complete cds [BC038367] KLA 1.48 1.25 1.26 1.87 2.00 1.89 1.26
ATP 1.05 1.09 .85 .71 .87 1.26 .82
KLA/ATP 1.34 1.43 1.21 1.19 2.66 2.32 2.56
Setd2
KLA  ATP  ATP+KLA
 NM_001081340 SET domain containing 2 (Setd2), mRNA [NM_001081340] KLA 1.04 .87 .95 .93 .97 1.06 1.02
ATP .93 .88 1.18 .76 1.38 1.67 1.03
KLA/ATP .83 .86 1.19 .73 1.74 2.18 1.55
Setd7
KLA  ATP  ATP+KLA
 NM_080793 SET domain containing (lysine methyltransferase) 7 (Setd7), mRNA [NM_080793] KLA .71 .69 .72 .73 .72 .68 .77
ATP 1.02 .97 1.00 .91 .93 .78 .87
KLA/ATP .72 .70 .78 .68 .95 .78 .70
Setd8
KLA  ATP  ATP+KLA
 NM_030241 SET domain containing (lysine methyltransferase) 8 (Setd8), mRNA [NM_030241] KLA 1.16 1.14 1.11 1.56 2.17 2.16 2.51
ATP 1.07 1.22 1.19 1.33 2.57 3.16 1.52
KLA/ATP 1.23 1.22 1.24 1.37 2.59 2.91 2.19
Setdb1
KLA  ATP  ATP+KLA
 AF546078 ERG-associated protein lacking the SET domain mRNA, complete cds, alternatively spliced. [AF546078] KLA .91 .90 .90 .93 1.03 .99 .98
ATP .97 .93 .92 .90 .92 .91 1.04
KLA/ATP .90 .91 .87 .89 .91 .85 .93
Setdb1
KLA  ATP  ATP+KLA
 NM_018877 SET domain, bifurcated 1 (Setdb1), mRNA [NM_018877] KLA .58 .58 .62 .63 .93 1.08 .92
ATP 1.19 1.28 1.09 .98 .57 .67 1.04
KLA/ATP .68 .60 .57 .62 .58 .76 1.80
Setdb2
KLA  ATP  ATP+KLA
 AK089197 NOD-derived CD11c +ve dendritic cells cDNA, RIKEN full-length enriched library, clone:F630035N16 product:hypothetical protein, full insert sequence. [AK089197] KLA 1.40 1.38 1.34 1.19 1.31 1.21 1.09
ATP 1.05 1.07 1.16 1.28 1.28 1.06 1.15
KLA/ATP 1.44 1.29 1.25 1.20 1.29 1.09 1.16
Setmar
KLA  ATP  ATP+KLA
 BC045208 SET domain and mariner transposase fusion gene, mRNA (cDNA clone MGC:49525 IMAGE:5067523), complete cds [BC045208] KLA .90 1.01 .98 1.03 1.01 1.06 1.15
ATP .94 .80 .73 .63 .63 .82 .96
KLA/ATP .97 .87 .83 .80 .83 .80 .88
Suv39h1
KLA  ATP  ATP+KLA
 NM_011514 suppressor of variegation 3-9 homolog 1 (Drosophila) (Suv39h1), mRNA [NM_011514] KLA .72 .77 .85 .75 .66 .61 .48
ATP 1.08 1.14 .86 1.06 .77 .62 .38
KLA/ATP .82 .81 .65 1.08 .77 .71 .35
Suv39h2
KLA  ATP  ATP+KLA
 NM_022724 suppressor of variegation 3-9 homolog 2 (Drosophila) (Suv39h2), mRNA [NM_022724] KLA .71 .72 .76 .72 .63 .70 .60
ATP .98 1.10 .93 .91 .89 .80 .64
KLA/ATP .72 .73 .79 .75 .69 .69 .54
Suv420h1
KLA  ATP  ATP+KLA
 NM_144871 suppressor of variegation 4-20 homolog 1 (Drosophila) (Suv420h1), mRNA [NM_144871] KLA 1.13 1.15 1.08 1.16 1.34 1.23 1.26
ATP .99 .99 1.01 .80 1.02 1.02 1.23
KLA/ATP 1.08 1.15 1.01 .86 1.09 1.02 1.32
Suv420h2
KLA  ATP  ATP+KLA
 NM_146177 suppressor of variegation 4-20 homolog 2 (Drosophila) (Suv420h2), transcript variant 1, mRNA [NM_146177] KLA .88 .85 .85 .88 .95 1.00 .78
ATP 1.00 1.05 .89 .96 .70 .80 .82
KLA/ATP .84 .88 .88 .91 .86 .80 .92
Tmlhe
KLA  ATP  ATP+KLA
 AK051339 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130036J04 product:EPSILON-TRIMETHYLLYSINE 2-OXOGLUTARATE DIOXYGENASE TMLH (EC 1.14.11.8) homolog [Rattus norvegicus], full insert sequence. [AK051339] KLA .79 .71 .83 .74 .69 .73 .69
ATP .95 .95 .99 .89 1.39 1.48 .75
KLA/ATP .72 .76 .88 1.02 1.43 1.41 .75
Tmlhe
KLA  ATP  ATP+KLA
 NM_138758 trimethyllysine hydroxylase, epsilon (Tmlhe), mRNA [NM_138758] KLA .62 .56 .53 .54 .67 .75 .83
ATP .98 1.02 1.20 1.25 .91 .69 1.14
KLA/ATP .63 .62 .62 .69 .63 .69 .91
Wbp7
KLA  ATP  ATP+KLA
 NM_029274 WW domain binding protein 7 (Wbp7), mRNA [NM_029274] KLA .93 1.00 .93 1.01 1.17 1.11 1.13
ATP .98 1.01 1.03 .99 1.21 1.24 1.07
KLA/ATP .98 .96 .99 .92 1.30 1.31 1.26
Whsc1
KLA  ATP  ATP+KLA
 AK079112 12 days embryo embryonic body between diaphragm region and neck cDNA, RIKEN full-length enriched library, clone:9430010A17 product:PUTATIVE WHSC1 PROTEIN homolog [Homo sapiens], full insert sequence. [AK079112] KLA .61 .55 .58 .60 .73 .85 .81
ATP 1.07 1.13 .90 .71 .47 .44 1.44
KLA/ATP .58 .54 .53 .49 .50 .43 .70
Whsc1
KLA  ATP  ATP+KLA
 NM_001081102 Wolf-Hirschhorn syndrome candidate 1 (human) (Whsc1), mRNA [NM_001081102] KLA .36 .37 .51 .51 .61 .85 .52
ATP 1.01 1.07 1.07 1.05 .67 .51 1.34
KLA/ATP .42 .40 .46 .43 .49 .64 1.06
Whsc1l1
KLA  ATP  ATP+KLA
 NM_001001735 Wolf-Hirschhorn syndrome candidate 1-like 1 (human) (Whsc1l1), transcript variant 1, mRNA [NM_001001735] KLA 3.60 3.85 5.03 5.03 4.58 3.41 1.38
ATP 1.00 1.02 1.12 1.17 1.10 2.00 1.09
KLA/ATP 3.42 4.08 4.30 4.44 3.58 3.95 3.17
Whsc1l1
KLA  ATP  ATP+KLA
 NM_001081269 Wolf-Hirschhorn syndrome candidate 1-like 1 (human) (Whsc1l1), transcript variant 2, mRNA [NM_001081269] KLA 3.03 2.87 3.21 2.82 2.62 2.14 1.26
ATP 1.08 .91 .85 .69 1.02 1.18 .52
KLA/ATP 2.92 2.65 2.66 1.81 3.21 1.68 .85